Imatinib - Novartis
At a glance
- Drug Originator Novartis
- Drug Class Amines; Anti-inflammatories; Antineoplastics; Antivirals; Benzamides; Eye disorder therapies; Piperazines; Pyridines; Pyrimidines; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Bcr-abl tyrosine kinase inhibitors; Platelet-derived growth factor receptor antagonists; Proto oncogene protein c-kit inhibitors; Signal transduction pathway inhibitors
- USA Patent Applicants NOVARTIS
- USA Patents 5
- NDAs 2
- Patent Applications 2,739
Table of Contents

Disclaimer